Philosys Healthcare, COVID-19 (Plasma Therapy/Plasma Therapeutics) Theme Rises 5.05% Up

On the 6th, the COVID-19 (plasma treatment/plasma therapy) theme rose by 4.89% compared to the previous day, showing strength, while Philosis Healthcare, a related stock attracting attention, surged by 5.05% compared to the previous day. Philosis Healthcare is known as a specialized manufacturer of digital set-top boxes.

[Graph] Major stock price changes in the COVID-19 (plasma treatment/plasma therapy) theme

According to preliminary data compiled at 14:28, foreigners have been making large net purchases, buying 781,800 shares of Philosis Healthcare.

[Table] Net purchases by foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Philosis Healthcare's quant financial score is 13.83 points, ranking 8th in the quant financial ranking within the COVID-19 (plasma treatment/plasma therapy) related theme. This can be interpreted as Philosis Healthcare having relatively low investment attractiveness from a financial perspective. On the other hand, S-Mac ranked 1st in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.